Psychedelic advocates have long asserted that broader psychedelic use will lead to a more open, progressive society, but there are too many instances of right-wingers who have taken them for that to be true.

Could a liquid-delivery system meant to help maintain a personalized “scent bubble” quietly usher in the creation of wearable psychedelic microdosing technology? A U.S. patent for this system is just one among an increasing list of psychedelic-inspired intellectual properties.

Shlomi Raz, CEO of Eleusis Benefit Corporation, made false claims about psychedelics. We asked multiple ethnobotanists, a medical anthropologist, and a chemist if they could help us set the record straight.

Our statement on a recent Chacruna article by Dr. Bia Labate.

Can psychedelic civil disobedience really stimulate systemic reorganization?

Many predicted an ethical storm brewing in the lead-up to the explosion of for-profit interest in psychedelic pharmaceuticals. But, were their efforts to mitigate the damage enough to make a difference?

“Play the field right and there’s money to be made even off some of the shit companies purely based on the wave.”

The new leaders of the psychedelic medicalization industry seem to see themselves as above their own self-proposed rules.

After decades of psychedelic nonprofits paving regulatory pathways and priming wealthy investors, for-profits are moving in to reap the rewards.

Psychedelic capitalists justify their decision to go for-profit in the ballroom of America’s most recent for-profit flop.